Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
MTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 18 | Edgemond JamesCFO AND TREASURER |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $1.02M 1,756 sh | Apr 10, 2026 |
| 17 | McCallion Kevin J.SVP, Products and Production |  MASS908 Devices Inc.Open-market sale · 10b5-1 plan | SELL | $131K 18.6K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Van Well DaanChief Legal Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $9,424 1,988 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Van Well DaanChief Legal Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $14K 2,861 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $14K 2,800 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Savitz RyanEVP, CFO & CBO |  DNTHDianthus Therapeutics, Inc. /DE/Open-market sale · 10b5-1 plan | SELL | $739K 8,224 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Muken RossPresident | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $9,239 1,950 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $9,152 1,931 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Cardoza GeorgeChief Financial Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $6,801 1,403 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $14K 2,800 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Clark Joseph GatesSVP and Pres, Optimized LED |  PENGPenguin Solutions, Inc.Open-market sale · 10b5-1 plan | SELL | $283K 12.5K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $1.25M 8,100 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $9,176 1,936 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $14K 2,800 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Papadopoulos DidierPresident of Aircraft OEM |  JOBYJoby Aviation, Inc.Open-market sale · 10b5-1 plan | SELL | $2,295 271 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $9,244 1,950 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Muken RossPresident | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $13K 2,786 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Rezvan MitraChief Accounting Officer |  SAILSailPoint, Inc.Open-market sale · 10b5-1 plan | SELL | $1,978 162 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Rezvan MitraChief Accounting Officer | SAILSailPoint, Inc. Open-market sale · 10b5-1 plan | SELL | $38K 3,310 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Rezvan MitraChief Accounting Officer | SAILSailPoint, Inc. Open-market sale · 10b5-1 plan | SELL | $22K 1,681 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Yeh Kuanling AmyChief Technology Officer | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $28K 3,000 sh | Apr 10, 2026 traded Apr 10, 2026 |
| 16 | Valente ManuelaChief People Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $19K 3,824 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 15 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $710K 1,224 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 15 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $915K 1,586 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 15 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $934K 1,617 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 14 | Tamari ShaharDirector, COO |  GLBEGlobal-E Online Ltd.Open-market sale · 10b5-1 plan | SELL | $129K 4,007 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 14 | Schlachet AmirDirector, CEO | GLBEGlobal-E Online Ltd. Open-market sale · 10b5-1 plan | SELL | $129K 4,001 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 13 | Lee Chan HenrySVP, General Counsel | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $103K 332 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 13 | Brown Christopher D.Director | MASS908 Devices Inc. Open-market sale · 10b5-1 plan | SELL | $106K 15.0K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 13 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $463K 3,200 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 11 | Brooks Jayme L.Chief Financial Officer |  LMBLimbach Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $287K 3,366 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 11 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $322K 560 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 11 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $659K 1,139 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 10 | McCallion Kevin J.SVP, Products and Production | MASS908 Devices Inc. Open-market sale · 10b5-1 plan | SELL | $38K 5,420 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 9 | Brown Christopher D.Director | MASS908 Devices Inc. Open-market sale · 10b5-1 plan | SELL | $52K 7,392 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 9 | Brown Christopher D.Director | MASS908 Devices Inc. Open-market sale · 10b5-1 plan | SELL | $124K 17.6K sh | Apr 10, 2026 traded Apr 10, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $94K 162 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 6 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $74K 500 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 6 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $250K 1,700 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 6 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $192K 1,300 sh | Apr 10, 2026 traded Apr 8, 2026 |